相关实验视频
Updated: Sep 20, 2025

08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
1.2K
维姆塞尔提尼布:首次获得批准
1Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. dru@adis.com.
Drugs
|May 25, 2025
概括
维姆塞尔提尼布是一种新型的口服激酶抑制剂,已获批准用于性巨细胞瘤 (TGCT). 它向殖民地刺激因子1受体 (CSF1R),为TGCT患者提供新的治疗选择.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 殖民地刺激因子1受体 (CSF1R) 的活性与紧突巨细胞瘤 (TGCT) 的病原发生有关.
- 针对CSF1R是一个潜在的治疗策略来管理TGCT.
研究的目的:
- 总结一下vimseltinib的发展里程碑.
- 为了突出维姆塞尔蒂尼布在TGCT治疗中的首次批准.
主要方法:
- 维姆塞尔提尼布是一种口服的酶抑制剂,向CSF1R.
- 开发涉及研究CSF1R作为治疗点.
主要成果:
- 维姆塞尔提尼布在2025年2月获得了美国的首次批准.
- 批准适用于症状TGCT的成年患者.
结论:
- 维姆塞尔提尼布为TGCT提供了一种新的口服治疗方法.
- 该药物适用于手术可能导致显著功能障碍或致病率的患者.
更多相关视频
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
27.5K
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
1.9K
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
267
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
267